These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33400014)

  • 1. Translating Knowledge About the Immune Microenvironment of Gastrointestinal Stromal Tumors into Effective Clinical Strategies.
    Chantharasamee J; Adashek JJ; Wong K; Eckardt MA; Chmielowski B; Dry S; Eilber FC; Singh AS
    Curr Treat Options Oncol; 2021 Jan; 22(1):9. PubMed ID: 33400014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune system and gastrointestinal stromal tumor: a wealth of opportunities.
    Tan Y; Garcia-Buitrago MT; Trent JC; Rosenberg AE
    Curr Opin Oncol; 2015 Jul; 27(4):338-42. PubMed ID: 26049274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of immunotherapy for gastrointestinal stromal tumor.
    Tan Y; Trent JC; Wilky BA; Kerr DA; Rosenberg AE
    Cancer Gene Ther; 2017 Mar; 24(3):130-133. PubMed ID: 28186088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors.
    Roulleaux Dugage M; Jones RL; Trent J; Champiat S; Dumont S
    Front Immunol; 2021; 12():715727. PubMed ID: 34489967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Infiltration, Cancer Stemness, and Targeted Therapy in Gastrointestinal Stromal Tumor.
    Wang J; Ren H; Wu W; Zeng Q; Chen J; Han J; Lin M; Zhang C; He Y; Li M
    Front Immunol; 2021; 12():691713. PubMed ID: 34925310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors.
    Rusakiewicz S; Semeraro M; Sarabi M; Desbois M; Locher C; Mendez R; Vimond N; Concha A; Garrido F; Isambert N; Chaigneau L; Le Brun-Ly V; Dubreuil P; Cremer I; Caignard A; Poirier-Colame V; Chaba K; Flament C; Halama N; Jäger D; Eggermont A; Bonvalot S; Commo F; Terrier P; Opolon P; Emile JF; Coindre JM; Kroemer G; Chaput N; Le Cesne A; Blay JY; Zitvogel L
    Cancer Res; 2013 Jun; 73(12):3499-510. PubMed ID: 23592754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors.
    Seifert AM; Zeng S; Zhang JQ; Kim TS; Cohen NA; Beckman MJ; Medina BD; Maltbaek JH; Loo JK; Crawley MH; Rossi F; Besmer P; Antonescu CR; DeMatteo RP
    Clin Cancer Res; 2017 Jan; 23(2):454-465. PubMed ID: 27470968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers.
    Li B; Chen H; Yang S; Chen F; Xu L; Li Y; Li M; Zhu C; Shao F; Zhang X; Deng C; Zeng L; He Y; Zhang C
    Mol Cancer; 2023 Apr; 22(1):71. PubMed ID: 37072770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy of Gastrointestinal Stromal Tumors].
    Zhu CZ; Liu D; Kang WM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):696-701. PubMed ID: 31699203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST).
    Cameron S; Gieselmann M; Blaschke M; Ramadori G; Füzesi L
    Int J Clin Exp Pathol; 2014; 7(7):3563-79. PubMed ID: 25120735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Targeted therapy combined with immunotherapy in gastrointestinal stromal tumor: a new era of hope and challenges].
    Zhao W; Cao H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):966-971. PubMed ID: 28900984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages and CD8
    Zhang JQ; Zeng S; Vitiello GA; Seifert AM; Medina BD; Beckman MJ; Loo JK; Santamaria-Barria J; Maltbaek JH; Param NJ; Moral JA; Zhao JN; Balachandran V; Rossi F; Antonescu CR; DeMatteo RP
    Cancer Immunol Res; 2018 Apr; 6(4):434-447. PubMed ID: 29467128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation.
    Indio V; Ravegnini G; Astolfi A; Urbini M; Saponara M; De Leo A; Gruppioni E; Tarantino G; Angelini S; Pession A; Pantaleo MA; Nannini M
    Front Immunol; 2020; 11():851. PubMed ID: 32670260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of immune microenvironment in gastrointestinal stromal tumours.
    Blakely AM; Matoso A; Patil PA; Taliano R; Machan JT; Miner TJ; Lombardo KA; Resnick MB; Wang LJ
    Histopathology; 2018 Feb; 72(3):405-413. PubMed ID: 28871595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell transcriptome analysis revealed the heterogeneity and microenvironment of gastrointestinal stromal tumors.
    Mao X; Yang X; Chen X; Yu S; Yu S; Zhang B; Ji Y; Chen Y; Ouyang Y; Luo W
    Cancer Sci; 2021 Mar; 112(3):1262-1274. PubMed ID: 33393143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of imatinib resistance associated with downregulation of c-kit expression in recurrent gastrointestinal stromal tumor (GIST): optimal timing of resection.
    Dudeja V; Armstrong LH; Gupta P; Ansel H; Askari S; Al-Refaie WB
    J Gastrointest Surg; 2010 Mar; 14(3):557-61. PubMed ID: 20033343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
    Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
    Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.
    Balachandran VP; Cavnar MJ; Zeng S; Bamboat ZM; Ocuin LM; Obaid H; Sorenson EC; Popow R; Ariyan C; Rossi F; Besmer P; Guo T; Antonescu CR; Taguchi T; Yuan J; Wolchok JD; Allison JP; DeMatteo RP
    Nat Med; 2011 Aug; 17(9):1094-100. PubMed ID: 21873989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours.
    Barrios CH; Blackstein ME; Blay JY; Casali PG; Chacon M; Gu J; Kang YK; Nishida T; Purkayastha D; Woodman RC; Reichardt P
    Eur J Cancer; 2015 Nov; 51(16):2423-33. PubMed ID: 26248685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.
    Nishida T; Blay JY; Hirota S; Kitagawa Y; Kang YK
    Gastric Cancer; 2016 Jan; 19(1):3-14. PubMed ID: 26276366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.